A

Active Director Director DIN 10674594
DIN 10674594 First appointment Jun 2024 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2024
Shareholding value •••• Premium profile

About Anzarkhan

Data last updated:

Anzarkhan is a Director at Pharmanet Medical Services Private Limited (since 2024). The company operates in Trading. Pharmanet Medical Services Private Limited reported revenue of ₹38.3 Lakh (FY 2024).

DIN 10674594
Primary Designation Director
Industry Trading
First Appointment 29 Jun 2024
Oldest Company Age 14 yrs
Largest company Pharmanet Medical Services Private Limited · ₹38.3 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 Jun 20242012₹38.3 Lakh (FY 2024)Active

Directorship timeline

Open interactive timeline →
Pharmanet Medical Services Private Limited
Premium access

Shareholding and investment profile for Anzarkhan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anzarkhan

Anzarkhan currently holds 1 directorship: Pharmanet Medical Services Private Limited (Director, since 29 Jun 2024, revenue ₹38.3 Lakh (FY 2024)).

Anzarkhan was first appointed on 29 Jun 2024 as Director at Pharmanet Medical Services Private Limited.

The current boards of Anzarkhan's companies include Asif Muhammed Haneefa (Pharmanet Medical Services Private Limited), Sasidharan Madhavan (Pharmanet Medical Services Private Limited), Shibi George (Pharmanet Medical Services Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available